QOIL .0002-1ST-NEWS-SINCE-ICE-AGE~~ Quest Oil Announces

New Post Public Reply Private Reply Replies (0) Message Board

Jul 17, 2012 at 10:28 AM

QOIL .0002-1ST-NEWS-SINCE-ICE-AGE~~

Quest Oil Announces Corporate Revitalization and Enters $126 Billion Enhanced Oil Recovery Market
New Initiative Greatly Increases Projected Revenue and Asset Valuations 07/17 09:30 AM

RENO, NV -- (MARKETWIRE) -- 07/17/12 -- Quest Oil Corp (QOIL:$0.0002,$0.0001,100.00%) announced today the official start of the company's revitalization and the commencement of its new Enhanced Oil Recovery (EOR) Initiative. The Company is actively negotiating for the acquisition of a number of oil production properties and related technologies that will both increase production of properties and provide licensing revenue through the use of its technology by third-party producers.
The global market for ERO, estimated by SBI Reports, a leading industrial market research reporting group, to be at more than $126.02 billion in 2011, has shown exciting growth since 2007, when the market totalled $54.96 billion. Technological challenges, hazy regulations, and high implementation costs have often been inhibitory to EOR projects, but this is quickly changing. Government interest and generous investments are helping to spur new developments in technology.
EOR refers to a variety of oil producing methods, by which 70% - 90% more oil is produced from oil wells than is typically extracted by conventional oil production methods. Some of the more common EOR methods include steam, gas or chemical injection, which improve the viscosity of the oil, enabling the oil to flow more freely out of the well.
The Company is currently assessing the acquisition of a number of properties and will provide timely announcements as to the progress of these initiatives as negotiations progress.
The Company anticipates the completion and subsequent announcement of planned EOR acquisitions and several new oil and gas production and property acquisition transactions -- all of which are expected to significantly expand the Company's oil and gas production base and revenue projections.
About Quest Oil Inc.
Quest Oil Inc. is an aggressive, well-managed independent oil production and technology company. The Company is an aggressively managed energy exploration, development and production company in the process of building oil & gas reserves and production. The Company specializes in the profitable business of employing Enhanced Oil Recovery technologies in the reworking & re-completing "marginal" oil & gas wells located in the thousands of mature oil & gas producing fields, across much of the United States. The Company intends to foster rapid corporate growth through its ability to identify, acquire interests in, and rework oilfields that offer exceptionally attractive risk/reward parameters.
The Company seeks to acquire and develop economically attractive and geologically sound properties that have, in management's view, significant upside development and revenue potential, as well as related technologies that will both increase production of its properties and provide licensing revenue through the use of its technology by third-party producers. The Company operates its business as a central hub, utilizing our strengths in M&A, capital and resource management. We proactively minimize risk by teaming with experienced exploration companies and project operators, leveraging their experience and knowledge. Quest Oil's (QOIL:$0.0002,$0.0001,100.00%) development strategy includes the implementation of state of the art technologies that are deployed to enhance and rework existing, highly predictable wells, within proven oil and gas plays. By focusing on domestic, mature oil fields and proven gas reserves, Quest Oil (QOIL:$0.0002,$0.0001,100.00%) can reduce exploration risks and better manage logistics. In turn, we provide access to public company management and funding, creating greater value for our business partners and stakeholders alike. The Company is currently assessing additional business strategies and opportunities to augment and strengthen its core holdings.
Safe-Harbor Statement
This release contains statements or projections regarding future performance that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties. The company's filings contain various RISK FACTORS (and are incorporated on the Company's website "Investors" section by reference) and should be read before any investment decision.
Quest Oil Corporation (QOIL:$0.0002,$0.0001,100.00%)
Info@qoilcorp.com

Get more news on:SYMBOLS: QOILNEWS TYPE: SECTORS: Energy, Oil, Gas and Consumable Fuels

I ONLY POST WHAT I PLAY

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...